SecBot SecBot
DEFA14A ·Filed Apr 15, 2026

DXCM

DEXCOM INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001093557-26-000062
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine filing with no immediate trading implications. Investors should review the full proxy statement for details on director elections and executive compensation, but no market-moving information is contained in this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$61.01
T+0 close · Apr 15, 2026 · via day close
Latest settled
+22.86%
T+60 · $74.96
Vs SPY
+15.26%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 16 $61.01entry
  2. T+1 · 7mo ago +4.86%α +3.65% · $63.98
  3. T+5 · 7mo ago +2.74%α +1.75% · $62.68
  4. T+20 · 6mo ago −4.00%α −9.82% · $58.57
  5. T+60 · 4mo ago +22.86%α +15.26% · $74.96
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dexcom, Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming annual shareholder meeting. The filing contains standard disclosures about director elections, executive compensation, and other corporate governance matters, but does not contain any material new information or announcements.

Key Financial Metrics

Vote
director election

Key Facts

  • Filing is a standard proxy statement (DEFA14A) for the annual shareholder meeting
  • No new material information or announcements are included
  • Contains standard disclosures about director elections and executive compensation
  • Filing is routine and expected corporate governance documentation

Financial Impact

No material financial impact

Risk Factors

  • None identified - this is a routine filing

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001093557-26-000062
Document: 0001093557-26-000062-index-headers.html0001093557-26-000062
Document: 0001093557-26-000062-index.html0001093557-26-000062
Document: 0001093557-26-000062.txt0001093557-26-000062

Track record

16 reports on DXCM

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $79.92 Now $83.33 +4.27% settles Nov 17
  2. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $82.97 to $79.92 Now $83.33 +0.43% ▼ −3.68% −3.09% vs SPY
  3. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $82.29 to $79.41 Now $83.33 +1.26% ▼ −3.50% −0.80% vs SPY
  4. Oct 27, 202620d ago 144 Neutral 2/10 Entry $78.62 to $88.48 Now $83.33 +5.99% ▲ +12.54% +13.25% vs SPY
  5. Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $87.93 to $87.47 Now $83.33 +5.23% ▲ +0.52% +1.12% vs SPY
  6. Sep 14, 20269w ago 8-K Neutral 2/10 Entry $86.45 to $89.53 Now $83.33 −3.61% ▲ +3.56% +1.44% vs SPY
  7. Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $91.06 to $84.53 Now $83.33 −8.49% ▼ −7.17% −7.03% vs SPY
  8. Aug 24, 202612w ago Insider Cluster Neutral 2/10 Entry $89.16 to $90.14 Now $83.33 −6.54% ▲ +1.10% +1.64% vs SPY
  9. Aug 17, 202613w ago Insider Cluster Neutral 2/10 Entry $89.60 to $89.16 Now $83.33 −7.00% ▼ −0.49% −0.29% vs SPY
  10. Jul 21, 202616w ago Insider Cluster Neutral 2/10 Entry $71.43 to $75.14 Now $83.33 +16.66% ▲ +5.19% +7.60% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (13h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026